Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack

NCT04067492 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
47
Enrollment
INDUSTRY
Sponsor class

Stopped In view of the continuing insufficient patient recruitment in the study due to the difficult epidemiological situation and the need for rational allocation of company resources, as well as based on the results of the interim analysis.

Conditions

Interventions

Sponsor

R-Pharm

Collaborators